Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07481604
Eligibility Criteria:
Inclusion Criteria:
* Participants must meet all of the following criteria:
* Healthy adults aged 50 years or older
* Able to understand the study procedures and provide written informed consent
* Females and males of reproductive potential must agree to use medically acceptable contraception until 3 months after the last vaccination
* Females of childbearing potential must have a negative pregnancy test prior to vaccination
Exclusion Criteria:
* Participants meeting any of the following criteria will be excluded:
* History of herpes zoster prior to screening
* History of severe allergic reaction to vaccines or vaccine components
* Known immunodeficiency or immune dysfunction
* Prior vaccination with varicella or herpes zoster vaccine
* Use of immunosuppressive therapy or systemic steroids that may affect immune response
* Positive test for HCV, HBV, or HIV at screening
* Pregnant or breastfeeding women
* Any medical condition that, in the opinion of the investigator, would make participation unsafe or interfere with study evaluation
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT07481604
Study Brief:
Protocol Section:
NCT07481604